In the course of the formal investigation procedure the Commission received comments from the complainant as well as from several interested parties, amongst them a substantial submission by the Bundesverband der Pharmazeutischen Industrie (hereinafter ‘BPI’) and submissions by pharmaceutical companies that were either granted an exemption under the scheme or had applied for such an exemption.
36 4. COMMENTS FROM INTERESTED PARTIES, Decision_act (EU) 2015/1300
In forcesince 27 Mar 2015